Vivione Biosciences Inc. announced the termination of Ted Moskal as President of Vivione and its operating subsidiary, Vivione Biosciences, LLC. Day-to-day responsibilities with the FDA will be assumed by Chief Medical Officer, Dr. Matthew Gombrich.
1st Jan change | Capi. | |
---|---|---|
+14.52% | 3.1B | |
+31.41% | 2.06B | |
+8.00% | 1.51B | |
-11.54% | 1.19B | |
+14.37% | 726M | |
+9.28% | 674M | |
+33.12% | 556M | |
-4.17% | 500M | |
+25.78% | 462M |